The relatively rare infection, called mucormycosis, usually occurs in those with weakened immune systems.
Pfizer and BioNTech applied to the Food and Drug Administration (FDA) for full approval of their COVID-19 vaccine.
Doctors have successfully treated a patient who developed very rare blood clots after receiving the Johnson & Johnson with an alternative blood thinner to heparin.
Findings don't mean that summer weather will eliminate COVID-19; but it may give people a leg up against the disease.
A CDC advisory panel voted to recommend that the U.S. resume administering the Johnson & Johnson vaccine for people 18 years of age and older.
An ancient coronavirus may have infected the ancestors of people living in modern-day East Asia tens of thousands of years ago.
India reported 312,731 new COVID-19 infections on Thursday, the highest single-day increase ever reported worldwide.
U.S. overdose deaths surged during the first half of the COVID-19 pandemic, according to preliminary data from the CDC.
Dogs can sniff out SARS-CoV-2 in urine samples with 96% accuracy, according to a proof-of-concept study.
People vaccinated against COVID-19 may require booster shots within nine to 12 months of their initial vaccination.
Leaving middle seats empty on airplanes helps reduce COVID exposure to passengers, a new CDC study finds.
The CDC and FDA are recommending a pause in administering the J&J vaccine to investigate reports of 6 cases of rare blood clots.
A monoclonal antibody cocktail developed by Regeneron reduced risk of developing symptomatic COVID-19 by 81% in household contacts living with a positive case, company said.
The company hopes to make the vaccine available to the age group before the start of the fall school year.